MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1

Reference

• Liu, Yang, Deng, Zhouÿ, Q, Zhao (R, et al. The reduced miR-144-3p promotes the progression of lung adenocarcinoma by improving the expression of EZH2. Cancer medicine. 2018; 7(11):5554–66.
   Web of Science ®Google Scholar
• Peng, Wang, Ĵ, Ĵ, Zhao Medium, Yellow S-K Alpha, Valley Y-Y, et al. Circulating non-coding RNA panels can be used as early detection predictive indicators of non-small cell lung cancer. Life Sciences. 2016; 151:235–42.
   Google Scholar
• Ariza-Prota Medium, Morales A, Grajeda Ĵ, Lopez Lisbon - (R, Cubero . . , Dorca Ĵ, et al. Successful cure for radioactive necrotization of the tracheal: the role of hyperbaric oxygen therapy. Chest. 2016; 150(6):e147–50.
   PubMed Web of Science ®Google Scholar
• Guo CW, Chen YM, Chao JY, Cai CM, Peng Huainan RP. Non-small cell lung cancer in very small and very old patients. Chest. 2000; 117(2):354–7.
   PubMed Web of Science ®Google Scholar
• Zhao small, high X, small, Liÿ, Feng X, Yuan X.’s MicroRNA-383-5p is used as a prognostic marker by proteophosphatase 2A as a cancer inhibitor and a cell proliferation inhibitor of pulmonary adenocarcinoma. Oncol Lett. 2017; 14(3):3573–9.
   PubMed Web of Science ®Google Scholar
• Raitoharju E, Seppälä I, Oksala N, Lyytikäinen L-P, Raitakari O, Viikari J, et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study. Mol Cell Endocrinol. 2014; 391(1–2):41–9.
   PubMed Web of Science ®Google Scholar
• Yu T, Li J, Yan M, Liu L, Lin H, Zhao F, et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene. 2015; 34(4):413–23.
   PubMed Web of Science ®Google Scholar
• Zhu D-Y, Li X-N, Qi Y, Liu D-L, Yang Y, Zhao J, et al. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomed Pharmacother. 2016; 81:79–85.
   PubMed Web of Science ®Google Scholar
• Li J, Sun P, Yue Z, Zhang D, You K, Wang J. miR-144-3p induces cell cycle arrest and apoptosis in pancreatic cancer cells by targeting proline-rich protein 11 expression via the mitogen-activated protein kinase signaling pathway. DNA Cell Biol. 2017; 36(8):619–26.
   PubMed Web of Science ®Google Scholar
• Bao H, Li X, Li H, Xing H, Xu B, Zhang X, et al. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. J Biosci. 2017; 42(1):103–11.
   PubMed Web of Science ®Google Scholar
• Mio F, Chiba K, Hirose Y, Kawaguchi Y, Mikami Y, Oya T, et al. A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation. Am J Hum Genet. 2007; 81(6):1271–7.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders (first of two parts). N Engl J Med. 1979; 301(1):13–23.
   PubMed Web of Science ®Google Scholar
• Wu YH, Chang TH, Huang YF, Huang HD, Chou CY. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene. 2014; 33(26):3432–40.
   PubMed Web of Science ®Google Scholar
• Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, et al. Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion. Br J Cancer. 2013; 109(12):3049–56.
   PubMed Web of Science ®Google Scholar
• Wu Y-H, Chang T-H, Huang Y-F, Chen C-C, Chou C-Y. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. Oncotarget. 2015; 6(27):23748–63.
   PubMedGoogle Scholar
• Chong I-W, Chang M-Y, Chang H-C, Yu Y-P, Sheu C-C, Tsai J-R, et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep. 2006; 16(5):981–8.
   PubMed Web of Science ®Google Scholar
• Fischer H, Stenling R, Rubio C, Lindblom A. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis. 2001; 22(6):875–8.
   PubMed Web of Science ®Google Scholar
• Lou N, Ruan A-M, Qiu B, Bao L, Xu Y-C, Zhao Y, et al. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Urol Oncol. 2017; 35(1):36.e7–e14.
   Web of Science ®Google Scholar
• Shabani N, Razaviyan J, Paryan M, Tavangar SM, Azizi F, Mohammadi-Yeganeh S, et al. Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC. Hum Pathol. 2018; 79:212–21.
   PubMed Web of Science ®Google Scholar
• Song J, Ma Q, Hu M, Qian D, Wang B, He N. The inhibition of miR-144-3p on cell proliferation and metastasis by targeting TOP2A in HCMV-positive glioblastoma cells. Molecules. 2018; 23(12):3259.
   Web of Science ®Google Scholar
• Gu J, Liu X, Li J, He Y. MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1. Cancer Cell Int. 2019; 19:15.
   PubMed Web of Science ®Google Scholar
• Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, et al. MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4. Onco Targets Ther. 2016; 9:4705–14.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao Y, Li F, Qiao B. MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer. J Physiol Biochem. 2019; 75(2):143–52.
   PubMed Web of Science ®Google Scholar
• Cao J, Han X, Qi X, Jin X, Li X. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p. Int J Oncol. 2017; 51(4):1115–23.
   PubMed Web of Science ®Google Scholar
• Wang W, Ge L, Xu X-J, Yang T, Yuan Y, Ma X-L, et al. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis. Radiol Oncol. 2019; 53(4):434–42.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012; 6(6):590–610.
   PubMed Web of Science ®Google Scholar
• Xiao W, Lou N, Ruan H, Bao L, Xiong Z, Yuan C, et al. Mir-144-3p promotes cell proliferation, metastasis, sunitinib resistance in clear cell renal cell carcinoma by downregulating ARID1A. Cell Physiol Biochem. 2017; 43(6):2420–33.
   PubMedGoogle Scholar
• Cheng ZX, Song YX, Wang ZY, Wang Y, Dong Y. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma. Eur Rev Med Pharmacol Sci. 2017; 21(18):4079–86.
   PubMed Web of Science ®Google Scholar
• Chen S, Li P, Li J, Wang Y, Du Y, Chen X, et al. MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR. Cell Physiol Biochem. 2015; 35(3):997–1007.
   PubMedGoogle Scholar
• Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, et al. A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis. 2009; 26(3):205–13.
   PubMed Web of Science ®Google Scholar
• Kim H, Watkinson J, Varadan V, Anastassiou D. Multicancer computational analysis showed that invasive variant reactions involved INHBA, THBS2 and COL11A1. BMC Med Genomics. 2010; 3:51.
   PubMedGoogle Scholar
• Anastassiou d, Rumjantseva V, Cheng w, yellow Ĵ, Canoll PD, Mountain City DJ, et al. Human cancer cell expression is a Slug-based cortation-interstate-converted gene expression feature obtained in the body. BMC Cancer. 2011; 11:529.
   Google Scholar